About us

About us

About us

About us

Unleash the Power of
Key Experts

Unleash the Power of
Key Experts

Unleash the Power of
Key Experts

Unleash the Power of
Key Experts

We empower biopharma and medical device companies with the best data and insights to select the key expert relationships that can accelerate treatment development and launch.
We empower biopharma and medical device companies with the best data and insights to select the key expert relationships that can accelerate treatment development and launch.
We empower biopharma and medical device companies with the best data and insights to select the key expert relationships that can accelerate treatment development and launch.
We empower biopharma and medical device companies with the best data and insights to select the key expert relationships that can accelerate treatment development and launch.

What we do

At Adnexi, we are dedicated to accelerating treatment development and launch for biopharma and medical device companies by profiling, segmenting and tracking key experts and their activities.

Meet our team

Co-Founders

Sandra Shpilberg

Co-Founder & CEO

Sandra Shpilberg

Co-Founder & CEO

Sandra Shpilberg

Co-Founder & CEO

Sandra Shpilberg

Co-Founder & CEO

Coby Shpilberg

Co-Founder & CTO

Team Members

Andrew Snyder

Project Manager

Jennie Jacobson, PhD

Medical Director

Meagan Mansfield

Strategic Accounts

Emily Rabbitt

Strategic Accounts

Austin Harrison

Data Analyst

Arushi Talwar

Data Analyst

Mellisa Andrade

Reporting Manager

Kimberly Wall

Finance

How we got started

A long time ago, our Co-Founder, Sandra, was a product director at BioMarin Pharmaceutical. One of her first strategic tasks was to learn about the Key Opinion Leaders (KOLs) for a rare disease. Back then, she put together a lot of Excel spreadsheets and manually filled every box. This was a pain for sure, and the data was outdated the next time a KOL published a new paper. She tried to do her job as best she could, but the reality was that

  • KOL discovery was slow and incomplete

  • There was no database to find complete profiles for these critical partners

  • There was no easy way to understand the collaboration networks already in place

  • The research was immediately outdated!

But first, Sandra took on another huge problem in the industry - finding patients for clinical trials. So, first, Sandra started and built Seeker Health. The company was sold to EVERSANA in late 2018. Fast forward to 2020 - the year the Covid pandemic started and her computer programmer son asked her the best question of all:

If you could build another company to solve a problem in biopharma, what would it be?

"I would build a company that solved the problem of finding KOLs efficiently, understanding their entire scientific history and how they collaborate with each other," she responded.

"I would build a company that solved the problem of finding KOLs efficiently, understanding their entire scientific history and how they collaborate with each other," she responded.

Sandra Shpilberg

Sandra Shpilberg

Co-Founder & CEO

Co-Founder & CEO

Ready to Supercharge ⚡ Treatment Development & Launch?

Fill out the contact form, and our team will reach out to schedule a meeting.

© 2024 Adnexi All rights reserved.

Project: Tolv Studio

Ready to Supercharge ⚡ Treatment Development & Launch?

Fill out the contact form, and our team will reach out to schedule a meeting.

© 2024 Adnexi All rights reserved.

Project: Tolv Studio

Ready to Supercharge ⚡ Treatment Development & Launch?

Fill out the contact form, and our team will reach out to schedule a meeting.

© 2024 Adnexi All rights reserved.

Project: Tolv Studio

Ready to Supercharge ⚡ Treatment Development & Launch?

Fill out the contact form, and our team will reach out to schedule a meeting.

© 2024 Adnexi All rights reserved.

Project: Tolv Studio